King Makes Play For Alpharma To Build Specialty Pain Franchise
This article was originally published in The Pink Sheet Daily
Executive Summary
Alpharma declines offer; King expresses hope for amicable resolution.
You may also be interested in...
King’s Dogged Pursuit of Alpharma Comes Up Aces
The combined specialty pharma company to be a leader in abuse-resistant pain meds.
King’s Dogged Pursuit of Alpharma Comes Up Aces
The combined specialty pharma company to be a leader in abuse-resistant pain meds.
Credit Woes Hitting Even Pharma
The pharmaceutical industry may take risks with R&D, but its disciplined approach to the balance sheet has helped insulate it from the rapidly spreading global credit mess. But even pharma will not be completely shielded